EDEN PRAIRIE, Minn. -- Sunshine Heart, Inc. announced today that its flagship C-Pulse® Heart Assist System will be featured in a clinical presentation at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The TCT symposium will take place October 27th through November 1st in San Francisco, CA at the Moscone Center.

On Monday, October 28th, an update will be provided on the ongoing European C-Pulse OPTIONS HF study in an oral presentation as part of the day's session entitled, "Device-Based Approaches for Heart Failure: Recent Developments and New Directions." The oral presentation will be included in Session III: LVAD's for "Less Sick Patients," at 10:39 a.m. (PDT) in Moscone West, Room 3009. The oral presentation will be led by Professor Thomas Krabatsch, of The German Heart Center in Berlin, Germany, a worldwide leading center in the treatment of heart failure patients.

In addition, the Company will host an analyst and investor breakfast on Tuesday, October 29th at 7:30 a.m. (PDT) held at the W Hotel San Francisco. Management will provide a brief corporate update followed by physician presentations listed below:

1) Professor Thomas Krabatsch, The German Heart Center, Berlin – Initial Clinical Observations on the OPTIONS HF Trial

2) Dr. Andrew Kao, St. Luke's Mid America Heart Institute, Kansas City – Single Center Experience with C-Pulse Patient Weaning

3) Dr. William Cohn, Texas Heart Institute – Progress with Fully Implantable Pump, Next Steps

The program will conclude with a question and answer session.

Source: Sunshine Heart, Inc.